RxDoctor Payments Data

Edwin I Perez Marrero, MD

Interventional Cardiology · San Juan, PRNPI 1043203268

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $83,050 of the $128,895 with a category attached, or 64.4%. Abbott accounts for 81.5% of it on its own, with 17 other manufacturers making up the rest.

$128,895in general payments, 2019–2025

Across 790 payments — averaging $163.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$105K
  • Edwards Lifesciences$9K
  • Medtronic$7K
  • Boston Scientific$5K
  • Terumo Medical Corporation$1K
  • Johnson & Johnson$393
  • plus $1K from 12 others

What the payments were for

  • Consulting fees$83,05064%
  • Speaking & faculty fees$24,66319%
  • Travel & lodging$4,7864%
  • Food & beverage$16,38313%
  • Education$140%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott323$105,015
Edwards Lifesciences159$9,194
Medtronic(2 entities)224$6,766
Boston Scientific26$4,974
Terumo Medical Corporation7$1,400
Johnson & Johnson11$393
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)15$287
Amgen3$156
Boehringer Ingelheim3$147
PBG Puerto Rico LLC5$129
Asahi Intecc USA, Inc.3$128
W. L. Gore & Associates, Inc.2$118
AstraZeneca4$77
Dexcom, Inc.1$28
Bayer Puerto Rico Inc.1$26
Novartis1$25
Merck1$19
Bayer1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$128,895 in reported general payments places this provider in the 85th percentile of 39 interventional cardiology providers in Puerto Rico.

See all interventional cardiology providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$38,680
Medicare patients
56
Services billed
271

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban294$193,221
EliquisApixaban141$96,061
BrilintaTicagrelor80$40,030
FarxigaDapagliflozin Propanediol52$35,536
EntrestoSacubitril/Valsartan37$28,456
Repatha PushtronexEvolocumab21$17,843
JardianceEmpagliflozin17$12,916
JanumetSitagliptin Phos/Metformin Hcl12$6,976
Metoprolol Succinate485$5,932
ClopidogrelClopidogrel Bisulfate605$5,288
Rosuvastatin Calcium421$4,814
Ranolazine ErRanolazine62$4,768
Atorvastatin Calcium496$4,374
Cilostazol110$3,162
Candesartan Cilexetil54$3,032

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$393$193,221294 claims
AstraZenecaBrilinta, Farxiga$77$75,566132 claims
NovartisEntresto$25$28,45637 claims
Boehringer IngelheimJardiance$147$12,91617 claims
MerckJanumet$19$6,97612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 39 interventional cardiology providers in Puerto Rico.

Other interventional cardiology in San Juan

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →